BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ozurdex dexamethasone intravitreal implant regulatory update

The U.K.'s NICE issued final guidance recommending use of Allergan's Ozurdex dexamethasone intravitreal implant to treat macular edema following central retinal vein occlusion (CRVO) and following branch...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >